Molecular Partners Company

Molecular Partners is a clinical-stage biopharmaceutical company working to advance modern medicine and significantly improve the management of serious diseases. They are developing a powerful new class of potent, specific and versatile small protein therapies called DARPin® therapeutics.
Industry: PharmTech
Headquarters: Zurich
Estimated Revenue: $10M to $50M

Visit Website
Register and Claim Ownership